Centene Corporation 10-Q, filed Oct 27, 2026

Summary

Centene Corporation reported continued elevated medical cost trend and detailed regulatory pressure across its Medicaid, Marketplace, and Medicare Part D businesses, including Medicaid work and redetermination requirements under the One Big Beautiful Bill Act, the expiration of enhanced Advance Premium Tax Credits at the end of 2025, and Medicare Part D cost-sharing changes. The company said a 26-state lawsuit challenging CMS's interim rule on Medicaid work requirements, California's planned Medi-Cal transition of about 175,000 members, and possible federal funding reductions could create further delays and uncertainty for its membership and revenue.

Key points

• Centene attributed continued elevated medical cost trend to rising medical demand, state-level expansions of access to care, and the rapid availability of new high-cost pharmaceuticals.
• The One Big Beautiful Bill Act, passed in July 2025, requires work or community engagement for Medicaid expansion eligibility and more frequent redeterminations, changes Centene expects could raise the morbidity of the Medicaid expansion population largely beginning in 2027.
• A coalition of 26 states, including 24 Democratic attorneys general and two governors, challenged CMS's June 3, 2026 interim rule implementing the work requirements on June 29, 2026, seeking to block provisions it alleges are unlawful.
• California will move roughly 175,000 Medi-Cal members with Unsatisfactory Immigration Status from managed care to fee-for-service effective January 1, 2027, affecting Health Net's at-risk Medi-Cal contracts.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.